Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Burgers FH"'
Autor:
Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands., Burgers FH; Divisions of Medical Oncology & Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Janssen JC; Department of Medical Oncology and Surgical Oncology, Erasmus Medical Centre, 's Gravendijkwal 230, 3015CE Rotterdam, the Netherlands., Putker AE; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525GA Nijmegen, the Netherlands., Veenstra SPGR; Department of Medical Oncology, Amsterdam UMC location VUmc, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Aarts MJB; Department of Medical Oncology, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, 6229HX Maastricht, the Netherlands., Hehenkamp KW; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands., Doornebosch VLE; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512KZ Enschede, the Netherlands., Verhaert M; Department of Medical Oncology, Laboratory of Medical and Molecular Oncology (LMM0), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Belgium., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162BG Sittard-Geleen, the Netherlands., Chatzidionysiou K; Rheumatology Unit, Department of Medicine, Karolinska Institute, 171 77 Stockholm, Sweden., Llobell A; R3 Rheumatology, Parc Taulí University Hospital, Sabadell, Barcelona 1-08208, Spain., Barros M; Department of Clinical Oncology, AC Camargo Cancer Center, R. Professor Antônio Prudente, 211 Liberdade, Sao Paulo, Brazil., Maria ATJ; Department of Internal Medicine, CHRU de Montpellier, 371 avenue du Doyen Gaston Giraud, 34090 Montpellier, France., Takeji A; Division of Rheumatology, Kanazawa University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8640, Japan., García Morillo JS; Unidad de Enfermedades Autoinmunes Sistemicas y Raras del Adulto, UGC Medicina Interna, Hospital Universitario Virgen del Rocío, Avda de Manuel Siurot s/n., 41013 Sevilla, Spain., Lidar M; Rheumatology Unit, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Israel., van Eijs MJM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Lundlaan 6, 3584EA Utrecht, the Netherlands., Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Aspeslagh S; Department of Medical Oncology, Laboratory of Medical and Molecular Oncology (LMM0), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Belgium., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512KZ Enschede, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands., Labots M; Department of Medical Oncology, Amsterdam UMC location VUmc, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525GA Nijmegen, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's Gravendijkwal 230, 3015CE Rotterdam, the Netherlands., Haanen JBAG; Divisions of Medical Oncology & Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands; Melanoma clinic, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 23, 1011 Lausanne, Switzerland., May AM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands. Electronic address: K.Suijkerbuijk@umcutrecht.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114172. Date of Electronic Publication: 2024 Jun 15.
Autor:
Borgers JSW; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Burgers FH; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schina A; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Van Not OJ; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Blank CU; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Sittard, The Netherlands., de Groot JWB; Isala Oncology Center, Zwolle, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Boer AMS; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van Thienen JV; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Haanen JBAG; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2024 Jan; Vol. 37 (1), pp. 15-20. Date of Electronic Publication: 2023 Aug 08.
Autor:
Borgers JSW; Department of Medical Oncology, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Burgers FH; Department of Medical Oncology, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Terveer EM; Netherlands Donor Feces Bank, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.; Center for Microbiome Analyses and Therapeutics at Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., van Leerdam ME; Department of Gastrointestinal Oncology, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., Korse CM; Department of Laboratory Medicine, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kessels R; Department of Biometrics, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Flohil CC; Department of Pathology, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blank CU; Department of Medical Oncology, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schumacher TN; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Dijk M; Clinical Trial Service Unit, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Henderickx JGE; Center for Microbiome Analyses and Therapeutics at Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Keller JJ; Netherlands Donor Feces Bank, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Gastroenterology, Haaglanden Medical Center, Den Haag, The Netherlands., Verspaget HW; Netherlands Donor Feces Bank, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Biobanking, Leiden University Medical Center, Leiden, The Netherlands., Kuijper EJ; Netherlands Donor Feces Bank, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.; Center for Microbiome Analyses and Therapeutics at Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Haanen JBAG; Department of Medical Oncology, Antoni Van Leeuwenhoek, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. j.haanen@nki.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2022 Dec 30; Vol. 22 (1), pp. 1366. Date of Electronic Publication: 2022 Dec 30.